If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Appointments by Grupo Clarin Board

3 May 2017 14:02

RNS Number : 0811E
Grupo Clarin S.A.
03 May 2017
 

GRUPO CLARIN S.A.

Grupo Clarín Board Appoints Chairman and Vice Chairman

and members of Audit Committee

 

On 2 May 2017, Grupo Clarín S.A. (the "Company") informed the Argentine Securities Commission and the Buenos Aires Stock Exchange that the Board of Directors of the Company had allocated positions on the Board for one fiscal year, as follows:

 

Chairman: Jorge Carlos Rendo

Vice-Chairman: Héctor Mario Aranda

Members: Pablo César Casey, Horacio Eduardo Quirós, Martín Gonzalo Etchevers, Ignacio Rolando Driollet, Lorenzo Calcagno, Alberto César Menzani, Gonzalo Blaquier, Sebastián Salaber.

Alternate Members: Hernán Pablo Verdaguer, Juan Ignacio Giglio, Francisco Iván Acevedo, Sebastián Bardengo, Antonio Aranda, Marcelo Alejandro Trivarelli, Carlos Rebay, Luis Germán Fernández, Francisco Saravia and Gervasio Colombres.

 

The Board also approved the composition of the Audit Committee as follows, Messrs. Alberto César Menzani, Lorenzo Calcagno and Héctor Mario Aranda, as members, and Messrs. Pablo César Casey, Carlos Rebay and Luis Germán Fernández, as alternate members.

 

Enquiries:

 

In Buenos Aires:

Agustín Medina Manson / Patricio Gentile

Grupo Clarín

Tel: +5411 4309 7215

Email: investors@grupoclarin.com 

 

In London:

Alex Money

Jasford IR

Tel: +44 20 3289 5300

Email: alexm@jasford.com 

 

In New York:

Melanie Carpenter

I-advize Corporate Communications

Tel: +1 212 406 3692

Email: clarin@i-advize.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUORORBAAVRAR

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS